At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Ketamine 1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
In Brief
A clinical study evaluating Ketamine and Dexmedetomidine for Duchenne Muscular Dystrophy. Completed, enrolled 53 participants across 1 site.
Detailed Summary
This is an interventional study on Duchenne muscular dystrophy patients who will be receiving sedation for a muscle biopsy as part of another study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDuchenne Muscular Dystrophy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedJul 2012
Primary CompletionApr 2013
Study CompletionJun 2013
TodayJul 2026
First PostedJul 20, 2012
Enrollment StartAug 1, 2011
Primary CompletionApr 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 14.0 years ago
Interventions
Ketaminedrug
1 mg/kg IV, additional doses of 0.5 mg/kg as needed
Dexmedetomidinedrug
0.5 mcg/kg/hr IV